Could a simple blood test spot breast cancer earlier?
NCT ID NCT05798338
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new, highly sensitive blood test to measure tiny particles called extracellular vesicles that are released by breast cancer cells. Researchers will compare levels in women with early or metastatic breast cancer to healthy controls. The goal is to see if this test can help diagnose breast cancer or monitor treatment response without needing a tissue biopsy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood test to help detect breast cancer earlier or track how it responds to treatment.
- What could go wrong
- This is an early-stage study with only 105 participants, so the test may not prove accurate enough for widespread use. It is not a treatment study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istituti Clinici Scientifici Maugeri SpA
RECRUITINGPavia, Lombardy, 27100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?